ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31712-10mM(1mLinDMSO) |
|
1445846-30-9 |
GPR84 antagonist 8
|
0 | C23H23N3O5 | |
GC31711-100mg |
|
1046787-18-1 |
PKC-IN-1
|
0 | C25H37FN8O2 | |
GC31711-50mg |
|
1046787-18-1 |
PKC-IN-1
|
0 | C25H37FN8O2 | |
GC31711-10mg |
|
1046787-18-1 |
PKC-IN-1
|
0 | C25H37FN8O2 | |
GC31711-5mg |
|
1046787-18-1 |
PKC-IN-1
|
0 | C25H37FN8O2 | |
GC31711-2mg |
|
1046787-18-1 |
PKC-IN-1
|
0 | C25H37FN8O2 | |
GC31711-10mM(1mLinDMSO) |
|
1046787-18-1 |
PKC-IN-1
|
0 | C25H37FN8O2 | |
GC31710-100mg |
|
452-35-7 |
Ethoxzolamide (Redupresin)
|
0 | C9H10N2O3S2 | |
GC31710-10mM(1mLinDMSO) |
|
452-35-7 |
Ethoxzolamide (Redupresin)
|
0 | C9H10N2O3S2 | |
GC31709-100mg |
|
216167-82-7 |
Succinobucol (AGI-1067)
|
0 | C35H52O5S2 | |
GC31709-50mg |
|
216167-82-7 |
Succinobucol (AGI-1067)
|
0 | C35H52O5S2 | |
GC31709-25mg |
|
216167-82-7 |
Succinobucol (AGI-1067)
|
0 | C35H52O5S2 | |
GC31709-10mg |
|
216167-82-7 |
Succinobucol (AGI-1067)
|
0 | C35H52O5S2 | |
GC31709-5mg |
|
216167-82-7 |
Succinobucol (AGI-1067)
|
0 | C35H52O5S2 | |
GC31709-10mM(1mLinDMSO) |
|
216167-82-7 |
Succinobucol (AGI-1067)
|
0 | C35H52O5S2 | |
GC31708-500mg |
|
80012-43-7 |
Epinastine (WAL801)
|
0 | C16H15N3 | |
GC31708-100mg |
|
80012-43-7 |
Epinastine (WAL801)
|
0 | C16H15N3 | |
GC31708-50mg |
|
80012-43-7 |
Epinastine (WAL801)
|
0 | C16H15N3 | |
GC31708-10mM(1mLinDMSO) |
|
80012-43-7 |
Epinastine (WAL801)
|
0 | C16H15N3 | |
GC31707-25mg |
|
23094-71-5 |
Chebulagic acid
|
0 | C41H30O27 | |